Michel Mallaret

922 total citations
37 papers, 549 citations indexed

About

Michel Mallaret is a scholar working on Toxicology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michel Mallaret has authored 37 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Toxicology, 6 papers in Infectious Diseases and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michel Mallaret's work include Forensic Toxicology and Drug Analysis (6 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Infection Control in Healthcare (4 papers). Michel Mallaret is often cited by papers focused on Forensic Toxicology and Drug Analysis (6 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Infection Control in Healthcare (4 papers). Michel Mallaret collaborates with scholars based in France, United States and Netherlands. Michel Mallaret's co-authors include Céline Villier, Maurice Demattéis, Christiane Guillermet, Patrick Lévy, Sylvie Lantuéjoul, Cécile Julien, Evelyne Gozal, Nathalie Stürm, Marc Hommel and Assia Jaillard and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Stroke and Biomedicine & Pharmacotherapy.

In The Last Decade

Michel Mallaret

33 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Mallaret France 11 135 86 76 74 74 37 549
S. Alex Stalcup United States 15 134 1.0× 73 0.8× 33 0.4× 24 0.3× 196 2.6× 32 873
Motohiro Matoba Japan 18 233 1.7× 32 0.4× 185 2.4× 73 1.0× 9 0.1× 57 782
Ian Kronborg Australia 18 315 2.3× 254 3.0× 81 1.1× 231 3.1× 27 0.4× 27 1.1k
Brad Christensen United States 7 271 2.0× 24 0.3× 35 0.5× 32 0.4× 13 0.2× 8 569
Wolfram Woltersdorf United Kingdom 10 120 0.9× 117 1.4× 21 0.3× 20 0.3× 58 0.8× 10 610
A BERTOLINI Italy 11 55 0.4× 66 0.8× 97 1.3× 14 0.2× 38 0.5× 15 650
J. F. W. Haffner Norway 17 99 0.7× 17 0.2× 23 0.3× 33 0.4× 20 0.3× 55 1.1k
Oswaldo L. Ramos Brazil 14 82 0.6× 24 0.3× 58 0.8× 80 1.1× 31 0.4× 24 1.1k
J J T Tate United Kingdom 16 102 0.8× 34 0.4× 64 0.8× 40 0.5× 11 0.1× 36 1.2k
Jenny Foster United States 9 52 0.4× 14 0.2× 31 0.4× 33 0.4× 20 0.3× 21 483

Countries citing papers authored by Michel Mallaret

Since Specialization
Citations

This map shows the geographic impact of Michel Mallaret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Mallaret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Mallaret more than expected).

Fields of papers citing papers by Michel Mallaret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Mallaret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Mallaret. The network helps show where Michel Mallaret may publish in the future.

Co-authorship network of co-authors of Michel Mallaret

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Mallaret. A scholar is included among the top collaborators of Michel Mallaret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Mallaret. Michel Mallaret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lepelley, Marion, et al.. (2020). Update on bradykinin-mediated angioedema in 2020. Therapies. 75(2). 195–205. 11 indexed citations
2.
Cristante, Justine, et al.. (2020). Pneumocystis pneumonia can complicate medical treatment of hypercortisolism even in outpatients with Cushing's disease. Annales d Endocrinologie. 81(6). 551–560. 7 indexed citations
3.
Lepelley, Marion, et al.. (2017). Drug Related Deaths: Retrospective Analysis in a French Universitary Hospital. Clinical Therapeutics. 39(8). e93–e94. 1 indexed citations
4.
Khouri, Charles, Marion Lepelley, Céline Villier, Thierry Bougerol, & Michel Mallaret. (2016). Cyamémazine (Tercian®) et syndromes extrapyramidaux : exploration des cas contenus dans la base nationale de pharmacovigilance. Therapies. 72(3). 345–350. 2 indexed citations
5.
Mallaret, Michel, et al.. (2014). Hypersexualité induite par l’aripiprazole : à propos d’un cas et revue de la littérature. Therapies. 69(6). 525–527. 8 indexed citations
6.
Glaizal, Mathieu, et al.. (2012). Suicidal poisonings with methadone in France: Results of a two year national survey by the Toxicovigilance Network. Clinical Toxicology. 50(9). 841–846. 12 indexed citations
7.
Debruyne, Danièle, Reynald Le Boisselier, Samira Djezzar, et al.. (2010). La méphédrone : une designer drug d’usage récent en France. Therapies. 65(6). 519–524. 15 indexed citations
8.
Mallaret, Michel, et al.. (2008). Utilisation des nouveaux opioïdes en Soins Palliatifs. Médecine Palliative. 1(2). 69–87. 1 indexed citations
9.
Demattéis, Maurice, Cécile Julien, Christiane Guillermet, et al.. (2007). Intermittent Hypoxia Induces Early Functional Cardiovascular Remodeling in Mice. American Journal of Respiratory and Critical Care Medicine. 177(2). 227–235. 132 indexed citations
10.
Montastruc, Jean‐Louis, Philippe Arnaud, Ivan Berlin, et al.. (2003). Critères pharmacologiques d’un médicament pour la substitution de la pharmacodépendance aux opiacés. Therapies. 58(2). 123–125. 8 indexed citations
11.
Laval, G., et al.. (2002). Nouveaux antalgiques de niveau III de l’Organisation mondiale de la santé. La Revue de Médecine Interne. 23(1). 55–70. 3 indexed citations
12.
Saviuc, Philippe, et al.. (2000). Intoxication par les bromures et fausse hyperchlorémie. Annales Françaises d Anesthésie et de Réanimation. 19(5). 363–366. 2 indexed citations
13.
Soule, Hervé, Michel Mallaret, B. Chanzy, et al.. (1998). Résistance des virus dans l’environnement hospitalier : le point sur l’activité virucide des désinfectants utilisés à l’état liquide. Annales de biologie clinique. 56(6). 693–703. 3 indexed citations
14.
Demattéis, Maurice, Guy Lallement, & Michel Mallaret. (1998). Dextromethorphan and dextrorphan in rats: Common antitussives — Different behavioural profiles. Fundamental and Clinical Pharmacology. 12(5). 526–537. 27 indexed citations
15.
Gaudin, Philippe, et al.. (1997). Tendinopathies et fluoro-quinolones. 3(1). 69–75. 9 indexed citations
16.
Demattéis, Maurice, et al.. (1997). Evaluation of dextromethorphan and dextrorphan as a preventive treatment of soman toxicity in mice. Neuroscience Letters. 234(2-3). 91–94. 8 indexed citations
17.
Mallaret, Michel, et al.. (1997). Chlorhexidine ou polyvidone iodée pour les soins de cathéters intravasculaires ? Analyse de la littérature. Médecine et Maladies Infectieuses. 27(10). 827–832. 4 indexed citations
18.
Mallaret, Michel, et al.. (1995). Discriminative stimulus properties of dextromethorphan in rats. Biomedicine & Pharmacotherapy. 49(10). 456–464. 12 indexed citations
19.
Mallaret, Michel, et al.. (1990). [Human salmonellosis and turtles in France].. PubMed. 38(1). 71–5. 6 indexed citations
20.
Pollak, Pierre, et al.. (1987). Blood pressure effects of apomorphine and domperidone in parkinsonism.. PubMed. 45. 263–6. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Alex Stalcup Breakdown of academic impact, for papers by Motohiro Matoba Breakdown of academic impact, for papers by Ian Kronborg Breakdown of academic impact, for papers by Brad Christensen Breakdown of academic impact, for papers by Wolfram Woltersdorf Breakdown of academic impact, for papers by A BERTOLINI Breakdown of academic impact, for papers by J. F. W. Haffner Breakdown of academic impact, for papers by Oswaldo L. Ramos Breakdown of academic impact, for papers by J J T Tate Breakdown of academic impact, for papers by Jenny Foster
Rankless by CCL
2026